Contract award
MELINTA THERAPEUTICS, LLC
ADVANCE THE DEVELOPMENT OF TWO ANTIBIOTICS FOR USE IN THE PEDIATRIC POPULATION FOR THE TREATMENT OF SERIOUS BACTERIAL INFECTIONS WHERE MULTIDRUG-RESISTANT ORGANISMS ARE COMMON, AND 2) DEVELOP ANTIBIOTICS FOR USE IN PUBLIC HEALTH AND BIOTHREAT EMERGEN
- PIID
- 75A50123C00022
- Award key
- CONT_AWD_75A50123C00022_7505_-NONE-_-NONE-
- Recipient UEI
- H8K6F2A4KD49
- Source as of
- —
Current award value
$47,521,2483
Obligated to date
$47,521,2482
Potential with options
$164,300,7573
- Awarding agency
- Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response
- Contractor
- MELINTA THERAPEUTICS, LLC
- Place of performance
- Washington, District of Columbia
- Set-aside
- No set-aside used
- Pricing
- Cost Sharing
- Competition
- Full and Open Competition1 offers received
- Period of performance
- Jul 6, 2023 — Jun 30, 2030Through Aug 6, 2034 if all options are exercised
- Benchmark category
- Unclassified
Transaction history
Every action recorded against this award, in the order the government reported them.
| Mod | Action date | Reason | Obligation | Value at action |
|---|---|---|---|---|
| 0 | Jul 6, 2023 | Initial award | $20,522,757.00 | $47,521,248.00 |
| P00001 | May 13, 2024 | B | $1,047,233.00 | $47,521,248.00 |
| P00002 | Sep 5, 2024 | G | $4,615,469.00 | $47,521,248.00 |
| P00003 | Mar 28, 2025 | B | $0.00 | $47,521,248.00 |
| P00004 | Sep 12, 2025 | G | $12,784,824.00 | $47,521,248.00 |
| P00005 | Sep 25, 2025 | G | $8,550,965.00 | $47,521,248.00 |
| P00006 | Sep 18, 2026 | M | $0.00 | $47,521,248.00 |
Provenance
Which source record produced each displayed rollup figure.
| Field | Source | File | Retrieved | Parser | Artifact hash |
|---|---|---|---|---|---|
| awarding_agency_id | USAspending.gov | — | Sep 20, 2026 | usaspending_contract_csv@2026.08.2 | b54d7bc97e49 |
| contractor_id | USAspending.gov | — | Sep 20, 2026 | usaspending_contract_csv@2026.08.2 | b54d7bc97e49 |
| current_award_value | USAspending.gov | — | Sep 20, 2026 | usaspending_contract_csv@2026.08.2 | b54d7bc97e49 |
| naics_code | USAspending.gov | — | Sep 20, 2026 | usaspending_contract_csv@2026.08.2 | b54d7bc97e49 |
| potential_award_value | USAspending.gov | — | Sep 20, 2026 | usaspending_contract_csv@2026.08.2 | b54d7bc97e49 |
| psc_code | USAspending.gov | — | Sep 20, 2026 | usaspending_contract_csv@2026.08.2 | b54d7bc97e49 |
| total_obligated | USAspending.gov | — | Sep 20, 2026 | usaspending_contract_csv@2026.08.2 | b54d7bc97e49 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.
- 1Rollup values derive from 7 transaction records parsed from USAspending.gov, retrieved Sep 20, 2026 by transform awards@2026.08.1.
- 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
- 3Current and potential award values are taken from the latest reported action, not summed across modifications.